Form 4: DaVita Inc. Insider Trades: Chief Compliance Officer Sells Shares

DaVita Inc. reports insider transactions where Chief Compliance Officer James O. Hearty acquired and disposed of company stock, including the exercise of Stock Appreciation Rights.

Summary

• James O. Hearty, Chief Compliance Officer of DaVita Inc., engaged in several transactions involving the company's common stock.
• On May 14, 2026, Hearty acquired 5,784 shares of common stock at a price of $110.63 per share, potentially through the exercise of Stock Appreciation Rights (SARs).
• Following this acquisition, 3,231 shares were withheld to cover the base price for the SAR exercise, and an additional 1,117 shares were withheld for tax obligations.
• On May 15, 2026, Hearty sold 15,000 shares of common stock at a weighted average price of $193.983, with individual sales ranging from $193.360 to $199.840.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions involving the exercise of SARs and subsequent sales, without indicating significant positive or negative developments for the company.

Positives

• Acquisition of 5,784 shares of common stock at a price of $110.63, indicating potential for future appreciation.
• Successful exercise of Stock Appreciation Rights, which can provide a financial benefit to the executive.
• Sale of shares at a significant profit, with a weighted average price of $193.983, well above the acquisition price.

Negatives

• Disposition of 15,000 shares of common stock, which could be interpreted as a reduction in the executive's direct stake in the company.
• Withholding of 3,231 shares to cover the base price of SARs and 1,117 shares for tax obligations, reducing the net shares acquired.

Risks

• The filing does not explicitly mention any risks or challenges.
• Potential for negative market perception if the sale of a significant number of shares is interpreted as a lack of confidence by management.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Management Comments

• The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported by DaVita Inc. executives, are common in the healthcare services sector. These filings provide transparency into executive compensation and potential shifts in insider holdings, which investors often monitor.

Stakeholder Impact

• Shareholders: The sale of shares by an executive may influence market perception, though the transaction appears to be part of a planned SAR exercise and tax management.
• Employees: No direct impact mentioned.
• Creditors: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Customers: No direct impact mentioned.

Next Steps

• The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the Commission staff, the Issuer, or a security holder.

Key Dates

Keywords

DaVita Inc., DVA, Form 4, Insider Trading, Stock Appreciation Rights, Common Stock, Securities Exchange Act, Beneficial Ownership, Executive Compensation